CCR5 and TNF receptor 1-associated periodic fever syndrome: To assess the therapeutic effect of the CCR5 inhibitor in virus-induced FHF, maraviroc (a CCR5 antagonist) was administered to the MHV-3-FHF mouse model (Fig. 7A).